Cite
HARVARD Citation
Mease, P. et al. (2020). Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Psoriatic Arthritis: Final 5‐year Results from the Phase 3 FUTURE 1 Study. ACR open rheumatology. 2 (1), pp. 18-25. [Online].